FULCRUM THERAPEUTICS, INC. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/355fc4a5-fd2e-4d81-b547-ea8e7cb25e22/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-74.9M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-065197 |
| FY 2024 | $-9.7M | 2024-01-01 – 2024-12-31 | evidence 0001193125-26-197196 |
| FY 2023 | $-97.3M | 2023-01-01 – 2023-12-31 | evidence 0001193125-26-197196 |
| FY 2022 | $-109.9M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-006841 |
| FY 2021 | $-80.8M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002727 |
| FY 2020 | $-70.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-010715 |
| FY 2019 | $-82.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-008951 |
| FY 2018 | $-32.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-008951 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
FULCRUM THERAPEUTICS, INC. — all facts · Revenue · Operating Income